SEC Form 4 · accession 0002149618-26-000006
Editas Medicine, Inc. · EDIT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Daniel Scott Ory
Officer — EVP, Chief Medical Officer
Period of report
Sep 8, 2026
Accepted (ET)
Sep 9, 2026 · 4:58 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001650664
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $3.03 | Sep 8, 2026 | A | 950,000 | A | — | Sep 7, 2036 | Common Stock | 950,000 | 950,000 | D |
Explanation of responses
- F1This option was granted on September 8, 2026 and is scheduled to vest over four years, with 25% of the shares to vest on October 15, 2027 and the remaining 75% of the shares scheduled to vest in equal monthly installments thereafter through October 15, 2030.